Home › NDC Lookup › RxCUI directory › RxCUI 2611260

Bupropion hydrochloride 105 MG / dextromethorphan hydrobromide 45 MG Extended Release Oral... — RxCUI 2611260

RxNorm drug concept · Semantic clinical drug
RxCUI 2611260 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 7 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2611260
Official nameBupropion hydrochloride 105 MG / dextromethorphan hydrobromide 45 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbupropion HCl 105 MG / dextromethorphan HBr 45 MG Extended Release Oral Tablet
FDA products mapped3
Package NDCs mapped7
Reported Medicaid activity (SDUD)134,150 prescriptions · 49 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dextromethorphan: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It won't necessarily silence your cough entirely, but it does temporarily suppress the cough reflex and reduce how intense and frequent your cough is. It can also help reduce that...
  • What exactly does dextromethorphan do — will it stop my cough completely?
  • It depends on your child's age and the specific product. Most dextromethorphan products should not be given to children under 4 years old without a doctor's guidance. Some products...
  • This is a really important question. If your antidepressant is an MAOI (monoamine oxidase inhibitor), you absolutely cannot take dextromethorphan — not while you're on it, and not...
📖 Read our full Dextromethorphan guide →

🕸️ Concept Web — How Bupropion hydrochloride 105 MG / dextromethorpha... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Bupropion hydrochloride 105 MG / dextromethorphan hydrobromide 45 MG Extended Release Oral Tablet RxCUI 2611260

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Bupropion 42347
    • Dextromethorphan 3289
    • Bupropion / dextromethorphan 2611256
    • Bupropion hydrochloride 203204
    • Dextromethorphan hydrobromide 102490
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Auvelity 2611261
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Bupropion / dextromethorphan Extended Release Oral Tablet 2611259
    • Bupropion hydrochloride / dextromethorphan hydrobromide Extended Release Oral Tablet 2648536
    • Bupropion / dextromethorphan Oral Product 2611257
    • Bupropion / dextromethorphan Pill 2611258
    • Bupropion hydrochloride / dextromethorphan hydrobromide Oral Product 2663418
    • Bupropion hydrochloride / dextromethorphan hydrobromide Pill 2662512
    • Bupropion / dextromethorphan Extended Release Oral Tablet [Auvelity] 2611265
    • Bupropion hydrochloride / dextromethorphan hydrobromide Extended Release Oral Tablet [Auvelity] 2655370
    • +5 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

  5. Packs 4

    Fixed collections of drugs packaged and sold together, like dose packs.

Showing up to 8 concepts per family — 22 of 27 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

📦 FDA Products & Package NDCs

3 products · 7 package NDCs
7 package NDCs map to RxCUI 2611260 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
81968-0030-22 1 BOTTLE in 1 CARTON (81968-030-22) / 21 TABLET, MULTILAYER... AUVELITY Axsome Therapeutics, Inc. 2026-05-08
81968-0045-14 1 BOTTLE in 1 CARTON (81968-045-14) / 14 TABLET, MULTILAYER... AUVELITY Axsome Therapeutics, Inc. 2024-09-18
81968-0045-30 30 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE (81968-0... AUVELITY Axsome Therapeutics, Inc. 2022-08-18
81968-0045-31 1 BOTTLE in 1 CARTON (81968-045-31) / 30 TABLET, MULTILAYER... AUVELITY Axsome Therapeutics, Inc. 2024-05-10
81968-0045-60 60 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE (81968-0... AUVELITY Axsome Therapeutics, Inc. 2024-06-28
81968-0345-01 1 KIT in 1 KIT (81968-345-01) * 1 BOTTLE in 1 CARTON / 14... AUVELITY Axsome Therapeutics, Inc. 2026-06-01
81968-0345-03 1 KIT in 1 KIT (81968-345-03) * 1 BOTTLE in 1 CARTON / 14... AUVELITY Axsome Therapeutics, Inc. 2026-06-01
Observed labelers: Axsome Therapeutics, Inc. (7) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.